

Fundamental dimension Equity attribute | ACHPeer $0.2173▲+3.08% Cap $16.71MP/E -0.1x QuantScore28/100 | ACRSLeader $3.75▼-2.09% Cap $552.0MP/E -6.5x QuantScore47/100 | ALLOPeer $1.250.00% Cap $431.9MP/E -1.9x QuantScore42/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
45/100 |
55/100 |
43/100 |
Valuation Multiples, PEG & DCF upside | 33/100 | 0/100 | 0/100 |
Health Piotroski, Altman Z, leverage & liquidity | 20/100 | 50/100 | 46/100 |
Growth Revenue / earnings growth & margins | 10/100 | 40/100 | 53/100 |
Sentiment Analyst ratings, targets & revisions | 33/100 | 93/100 | 69/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | -0.1x | -6.5x | -1.9x |
Forward P/E (next FY) | 65.2x | -5.8x | -2.1x |
EV / EBITDA (TTM) | 7.8x | -7.1x | -3.0x |
Price / Sales | 0.0x | 67.2x | 93.1x |
Price / Free Cash Flow | -0.1x | -8.9x | -4.2x |
PEG ratio | -0.00 | -0.14 | -0.03 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 2 / 9 | 2 / 9 | 4 / 9 |
Altman Z-Score | 0.27 (Distress) | -2.73 (Distress) | -3.36 (Distress) |
Total debt / equity | -3.23 | 0.00 | 0.16 |
Quick ratio | 0.3x | 3.5x | 10.7x |
Interest coverage | 0.8x | — | -138.7x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | -74.2% | -58.2% | -100.0% |
Net income growth YoY | -203.5% | +50.8% | +25.9% |
Gross margin (TTM) | 44.8% | 95.6% | 100.0% |
Operating margin (FY) | 8.0% | -975.9% | — |
FCF margin (FY) | -11.0% | -602.0% | — |
5. Trailing price performancePrice change over period |
1M return | -70.4% | -30.3% | -25.1% |
3M return | -93.1% | -28.3% | -28.2% |
6M return | -93.4% | -12.8% | -45.9% |
Year to date | -92.2% | +24.6% | -8.8% |
1Y return | -96.1% | +74.4% | +4.2% |
3Y return | -98.5% | -24.5% | -55.0% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $-12.98 -6074.4% premium | $-0.8247 -122.0% premium | $-0.1549 -112.4% premium |
Wall Street consensus target | $1.50 +590.3% · range $1.50–$1.50 | $10.75 +186.7% · range $10.00–$12.00 | $26.53 +2022.4% · range $3.85–$55.00 |
Consensus stance | 13% Buy73% Hold13% Sell | 81% Buy19% Hold0% Sell | 63% Buy33% Hold3% Sell |